An unexpected discovery in a herpes lab might bring relief to cancer patients
June 29, 2017
| By Sabin Russell / Fred Hutch News Service
Drs. Jia Zhu and Tao Peng made a unexpected discovery while searching for a treatment for herpes: The virus prompts skin cells to make a protein that keeps sensory nerves healthy, and might lead to a treatment for peripheral neuropathy, a side effect of chemotherapy.
Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows
Dec. 20, 2016
| By Mary Engel / Fred Hutch News Service
The results of the phase 2, randomized, double-blind trial published today in JAMA showed that when people with genital herpes took a daily oral dose of pritelivir, they reduced their rate of viral shedding by half compared to when they took valacyclovir. They also had fewer genital sores and less pain.
New Hutch study predicts threshold of viral load for passing herpes from one person to another
March 25, 2014
| By Mary Engel
Fred Hutch researchers used mathematical models to predict viral loads below which transmission of the herpes virus is unlikely to occur. Preventing transmission is critical because there is no cure for herpes.